| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |